antitrust regulations – The Milli Chronicle

Saturday, November 8, 2025

Latest:

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle November 8, 2025November 8, 2025 antitrust regulations, biopharma growth, Eli Lilly competition, healthcare innovation, metabolic health market, Metsera deal, Metsera shareholder meeting, Novo Nordisk withdrawal, obesity drug market, obesity treatment innovation, Pfizer $10 billion merger, Pfizer acquisition, Pfizer strategic expansion., pharmaceutical investments, U.S. biotech mergers, weight-loss drug development

Pfizer secures $10 billion Metsera deal after Novo Nordisk withdraws

Pfizer’s $10 billion acquisition of Metsera marks a major victory for the U.S. pharmaceutical giant, strengthening its position in the